Adverse effects are uncommon, though some individuals may experience mild symptoms such as dizziness
The 2024 Yang paper in Journal for ImmunoTherapy of Cancer documented NNMT in cancer-associated fibroblasts driving tumour progression (PMID 39067875)
Will take my fourth dose in two days, which means Ive been taking this for less than three weeks
Its a triagonist , meaning it activates three key receptors: GLP-1, GIP, and glucagon
administration in increasing B12 levels, even with IF deficiency, although in severe deficiency i.m
Long-term maintenance of proper B12 levels can contribute to better neurological health, potentially reducing the risk of nerve damage and symptoms such as numbness or tingling in the hands and feet